<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bcl-2 protooncogene, originally discovered at the chromosomal breakpoint of the t(14;18) in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, is known to regulate the process of programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is thought to be one of the mechanisms involved in the development of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the possible association of bcl-2 protooncogene with the <z:mp ids='MP_0002006'>tumorigenesis</z:mp> of <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo>, the authors examined bcl-2 expression by immunohistochemistry in 49 <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo> and 7 <z:hpo ids='HP_0003005'>ganglioneuromas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The distribution of apoptotic cells was also examined by the TUNEL method (terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> nick end labeling) </plain></SENT>
<SENT sid="4" pm="."><plain>Bcl-2 oncoprotein was detected in the cytoplasm in 40 of 49 <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo> (81.6%) </plain></SENT>
<SENT sid="5" pm="."><plain>There was no correlation between bcl-2 oncoprotein expression and the clinical features of <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of bcl-2-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in <z:hpo ids='HP_0003005'>ganglioneuroma</z:hpo> was significantly lower than that in <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> (28.6%) (P &lt; .01) </plain></SENT>
<SENT sid="7" pm="."><plain>TUNEL stained the nuclei of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in 11 of 34 (32.4%) <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>TUNEL-positive cells tended to be located around calcifications in <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo> in patients less than 1 year old </plain></SENT>
<SENT sid="9" pm="."><plain>Examination of serial sections showed that apoptotic cells were distributed in the area where bcl-2 oncoprotein was not expressed </plain></SENT>
<SENT sid="10" pm="."><plain>What we have observed indicates that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> cells may be regulated by bcl-2 expression </plain></SENT>
<SENT sid="11" pm="."><plain>Our observations suggest that the survival of <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> cells might be promoted by bcl-2 expression and that bcl-2 might be associated with the <z:mp ids='MP_0002006'>tumorigenesis</z:mp> of <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo> </plain></SENT>
</text></document>